FDA Inspection 1216992 — Vastrax, Inc.
The FDA completed an inspection of Vastrax, Inc. on August 17, 2023 in Andover, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 17, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Andover, MA (United States)
Additional Details
Sponsor, Contract Research Organization